ADXN logo

Addex Therapeutics Ltd (ADXN) EBIT

Annual EBIT

-$11.73 M
+$10.03 M+46.09%

December 1, 2023

Summary

Performance

1-Year Change

+46.09%

3-Year Change

+14%

5-Year Change

-659.8%

15-Year Change

-252.31%

ADXN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.39%
ADXN annual earnings before interest & taxes is higher than 64.39% of companies in Healthcare sector

High & Low

All-time High

$20.89 M
ADXN annual earnings before interest & taxes is currently -156.15% below its historical high of $20.89 million

3-Year Low

-$21.76 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
ADXN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
ADXN next annual earnings announcement has not yet been scheduled

OtherADXNprofitabilitymetrics:

Annual Revenue

$1.80 M
ADXN annual revenue is $1.80 million

Annual Net Income

-$11.76 M
ADXN annual net profit is -$11.76 million

Annual EBITDA

-$11.39 M
ADXN annual EBITDA is -$11.39 million

Annual EPS

-$18.71
ADXN annual earnings per share is -$18.71

Quarterly EBIT

-$1.77 M
-$156.00 K-9.69%

September 1, 2024

Summary

Performance

3-Month Change

-9.69%

1-Year Change

-119.57%

3-Year Change

+63.13%

5-Year Change

+51.12%

ADXN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.03%
ADXN quarterly earnings before interest & taxes is higher than 67.03% of companies in Healthcare sector

High & Low

All-time High

-$398.90 K

3-Year Low

-$10.08 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNprofitabilitymetrics:

Quarterly Revenue

$62.30 K
ADXN quarterly revenue is $62.30 thousand

Quarterly Net Income

-$1.77 M
ADXN quarterly net profit is -$1.77 million

Quarterly EBITDA

-$1.70 M
ADXN quarterly EBITDA is -$1.70 million

Quarterly EPS

-$2.78
ADXN quarterly earnings per share is -$2.78

TTM EBIT

-$14.30 M
-$961.60 K-7.21%

September 1, 2024

Summary

Performance

3-Month Change

-7.21%

1-Year Change

-156.71%

3-Year Change

+14.48%

5-Year Change

+3.01%

ADXN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.66%
ADXN TTM earnings before interest & taxes is higher than 59.66% of companies in Healthcare sector

High & Low

All-time High

-$3.01 M

3-Year Low

-$22.79 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ADXN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
ADXN next earnings announcement has not yet been scheduled

OtherADXNprofitabilitymetrics:

TTM Revenue

$630.00 K
ADXN TTM revenue is $630.00 thousand

TTM Net Income

$5.72 M
ADXN TTM net profit is $5.72 million

TTM EBITDA

-$13.70 M
ADXN TTM EBITDA is -$13.70 million

TTM EPS

-$0.34
ADXN TTM earnings per share is -$0.34

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$11.73 M
ADXN annual earnings before interest & taxes is -$11.73 million

Annual Revenue

$1.80 M
ADXN annual revenue is $1.80 million

Annual Cost Of Goods Sold

-
ADXN annual cost of goods sold value is unknown

Annual Operating Expenses

$13.25 M
ADXN annual total operating expenses is $13.25 million

ADXN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.1%-119.6%-156.7%
3 y3 years+14.0%+63.1%+14.5%
5 y5 years-659.8%+51.1%+3.0%

ADXN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+46.1%-342.7%+82.5%-156.7%+37.3%
5 y5-yearat high+46.1%-342.7%+82.5%-156.7%+37.3%
alltimeall time-156.2%+70.3%-342.7%+82.5%-374.8%+37.3%

Addex Therapeutics Ltd EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.77 M(+9.7%)
-$14.30 M(+7.2%)
Jun 2024
-
-$1.61 M(+91.5%)
-$13.34 M(+8.4%)
Mar 2024
-
-$840.50 K(-91.7%)
-$12.30 M(+3.7%)
Dec 2023
-$11.73 M(-46.1%)
-$10.08 M(+1153.5%)
-$11.86 M(+113.0%)
Sep 2023
-
-$804.20 K(+38.8%)
-$5.57 M(-38.2%)
Jun 2023
-
-$579.40 K(+45.2%)
-$9.01 M(-43.3%)
Mar 2023
-
-$398.90 K(-89.5%)
-$15.90 M(-27.0%)
Dec 2022
-$21.76 M(+30.1%)
-$3.79 M(-10.8%)
-$21.78 M(-4.4%)
Sep 2022
-
-$4.25 M(-43.2%)
-$22.79 M(+1.5%)
Jun 2022
-
-$7.47 M(+18.9%)
-$22.45 M(+11.7%)
Mar 2022
-
-$6.28 M(+31.1%)
-$20.10 M(+20.3%)
Dec 2021
-$16.73 M(+22.6%)
-$4.79 M(+22.5%)
-$16.72 M(+17.2%)
Sep 2021
-
-$3.91 M(-23.7%)
-$14.27 M(+2.3%)
Jun 2021
-
-$5.12 M(+77.0%)
-$13.95 M(+15.9%)
Mar 2021
-
-$2.90 M(+23.7%)
-$12.04 M(-11.1%)
Dec 2020
-$13.64 M
-$2.34 M(-34.8%)
-$13.53 M(-8.9%)
Sep 2020
-
-$3.59 M(+11.7%)
-$14.86 M(-0.2%)
Jun 2020
-
-$3.21 M(-26.9%)
-$14.88 M(-7.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$4.39 M(+19.9%)
-$16.12 M(+9.4%)
Dec 2019
-$14.75 M(+855.1%)
-$3.66 M(+1.4%)
-$14.74 M(+33.1%)
Sep 2019
-
-$3.61 M(-18.9%)
-$11.08 M(+48.4%)
Jun 2019
-
-$4.45 M(+47.9%)
-$7.47 M(+147.9%)
Mar 2019
-
-$3.01 M
-$3.01 M
Dec 2018
-$1.54 M(-53.6%)
-
-
Dec 2017
-$3.33 M(+4.8%)
-
-
Dec 2016
-$3.18 M(-23.8%)
-
-
Dec 2015
-$4.17 M(+114.5%)
-
-
Dec 2014
-$1.94 M(-87.5%)
-
-
Dec 2013
-$15.60 M(-45.0%)
-
-
Dec 2012
-$28.37 M(-19.1%)
-
-
Dec 2011
-$35.06 M(+9.6%)
-
-
Dec 2010
-$32.00 M(-18.9%)
-
-
Dec 2009
-$39.44 M(-288.8%)
-
-
Dec 2008
$20.89 M(-171.5%)
-
-
Dec 2007
-$29.24 M(+78.5%)
-
-
Dec 2006
-$16.38 M
-
-

FAQ

  • What is Addex Therapeutics Ltd annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd annual EBIT year-on-year change?
  • What is Addex Therapeutics Ltd quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd quarterly EBIT year-on-year change?
  • What is Addex Therapeutics Ltd TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Addex Therapeutics Ltd?
  • What is Addex Therapeutics Ltd TTM EBIT year-on-year change?

What is Addex Therapeutics Ltd annual earnings before interest & taxes?

The current annual EBIT of ADXN is -$11.73 M

What is the all time high annual EBIT for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high annual earnings before interest & taxes is $20.89 M

What is Addex Therapeutics Ltd annual EBIT year-on-year change?

Over the past year, ADXN annual earnings before interest & taxes has changed by +$10.03 M (+46.09%)

What is Addex Therapeutics Ltd quarterly earnings before interest & taxes?

The current quarterly EBIT of ADXN is -$1.77 M

What is the all time high quarterly EBIT for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high quarterly earnings before interest & taxes is -$398.90 K

What is Addex Therapeutics Ltd quarterly EBIT year-on-year change?

Over the past year, ADXN quarterly earnings before interest & taxes has changed by -$961.60 K (-119.57%)

What is Addex Therapeutics Ltd TTM earnings before interest & taxes?

The current TTM EBIT of ADXN is -$14.30 M

What is the all time high TTM EBIT for Addex Therapeutics Ltd?

Addex Therapeutics Ltd all-time high TTM earnings before interest & taxes is -$3.01 M

What is Addex Therapeutics Ltd TTM EBIT year-on-year change?

Over the past year, ADXN TTM earnings before interest & taxes has changed by -$8.73 M (-156.71%)